Package 42806-659-30

Brand: entecavir

Generic: entecavir
NDC Package

Package Facts

Identity

Package NDC 42806-659-30
Digits Only 4280665930
Product NDC 42806-659
Product ID 42806-659_db290579-c9e1-44be-b03c-ad8a7efe5ce1
Description

30 TABLET in 1 BOTTLE, PLASTIC (42806-659-30)

Marketing

Marketing Status
Marketed Since 2020-06-02
Brand entecavir
Generic entecavir
Sample Package No

Linked Drug Pages (1)

Entecavir ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "db290579-c9e1-44be-b03c-ad8a7efe5ce1", "openfda": {"upc": ["0342806658307", "0342806659304"], "unii": ["5968Y6H45M"], "rxcui": ["485434", "485436"], "spl_set_id": ["af4f47e2-f556-40f2-a0fd-ff81e9f27429"], "manufacturer_name": ["EPIC PHARMA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE, PLASTIC (42806-659-30)", "package_ndc": "42806-659-30", "marketing_start_date": "20200602"}], "brand_name": "Entecavir", "product_id": "42806-659_db290579-c9e1-44be-b03c-ad8a7efe5ce1", "dosage_form": "TABLET", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Analog [EXT]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "42806-659", "generic_name": "Entecavir", "labeler_name": "EPIC PHARMA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Entecavir", "active_ingredients": [{"name": "ENTECAVIR", "strength": "1 mg/1"}], "application_number": "ANDA212126", "marketing_category": "ANDA", "marketing_start_date": "20200602", "listing_expiration_date": "20271231"}